Literature DB >> 21070167

Ultrastructural characteristics (or evaluation) of Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies or prion diseases.

Paweł P Liberski1, Beata Sikorska, Jean-Jacques Hauw, Nicolas Kopp, Nathalie Streichenberger, Pierrie Giraud, Jan Boellaard, Herbert Budka, Gabor G Kovacs, James Ironside, Paul Brown.   

Abstract

The authors report on a large series of human prion diseases to establish ultrastructural characteristics that may be useful for their diagnosis. For Creutzfeldt-Jakob disease (CJD and its variant, vCJD) and fatal familial insomnia (FFI) only vacuolation (spongiform change) and the presence of tubulovesicular structures are consistent findings. Other changes, such as the presence of myelinated vacuoles, branching cisternae, neuroaxonal dystrophy, and autophagic vacuoles, were present in different proportions in either CJD or FFI, but they are nonspecific ultrastructural findings that can also occur in other neurodegenerative conditions. The hallmark of Gerstmann-Sträussler-Scheinker disease (GSS) and vCJD is the amyloid plaque, but plaques of GSS and kuru are different than those of vCJD. Whereas the former are typical unicentric kuru type or multicentric plaques, the latter are unicentric florid plaques. Also, kuru plaques are nonneuritic, whereas GSS florid plaques are usually neuritic; however, a proportion of plaques from GSS was also found to have nonneuritic characteristics. Thus, the presence or absence of dystrophic neurites is not a discriminatory factor for GSS and vCJD. Furthermore, plaques from GSS with different mutations were also slightly different. In GSS with mutations P102L, 232T, and A117V plaques were stellate while in 1 case with 144 base-pair insertion and in GSS-A117V, round plaques were also observed, and typical primitive neuritic plaques, i.e., composed of dystrophic neurites with little or no amyloid, were found only in a P102L case from the original Austrian family. In 2 cases of sporadic CJD, the kuru stellate plaque predominated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070167     DOI: 10.3109/01913123.2010.491175

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  14 in total

1.  Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrPSc and Targeting PrPSc for Lysosomal Degradation.

Authors:  Joanna E Pankiewicz; Sandrine Sanchez; Kent Kirshenbaum; Regina B Kascsak; Richard J Kascsak; Martin J Sadowski
Journal:  Mol Neurobiol       Date:  2018-07-09       Impact factor: 5.590

2.  Generation of novel neuroinvasive prions following intravenous challenge.

Authors:  Patricia Aguilar-Calvo; Cyrus Bett; Alejandro M Sevillano; Timothy D Kurt; Jessica Lawrence; Katrin Soldau; Per Hammarström; K Peter R Nilsson; Christina J Sigurdson
Journal:  Brain Pathol       Date:  2018-07-05       Impact factor: 6.508

3.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

4.  Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Leo H Wang; Robert C Bucelli; Erica Patrick; Dhanashree Rajderkar; Enrique Alvarez Iii; Miranda M Lim; Gabriela Debruin; Victoria Sharma; Sonika Dahiya; Robert E Schmidt; Tammie S Benzinger; Beth A Ward; Beau M Ances
Journal:  J Neurol       Date:  2012-09-12       Impact factor: 4.849

5.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

6.  Electron microscopic and confocal laser microscopy analysis of amyloid plaques in chronic wasting disease transmitted to transgenic mice.

Authors:  Beata Sikorska; Agata Gajos; Andrzej Bogucki; Emil Zielonka; Christina Sigurdson; Pawel P Liberski
Journal:  Prion       Date:  2017-11-02       Impact factor: 3.931

Review 7.  Prion degradation pathways: Potential for therapeutic intervention.

Authors:  Rob Goold; Chris McKinnon; Sarah J Tabrizi
Journal:  Mol Cell Neurosci       Date:  2015-01-10       Impact factor: 4.314

8.  Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.

Authors:  Lilla Reiniger; Ilaria Mirabile; Ana Lukic; Jonathan Df Wadsworth; Jacqueline M Linehan; Michael Groves; Jessica Lowe; Ronald Druyeh; Peter Rudge; John Collinge; Simon Mead; Sebastian Brandner
Journal:  Acta Neuropathol Commun       Date:  2013-05-09       Impact factor: 7.801

9.  Identification of clinical target areas in the brainstem of prion-infected mice.

Authors:  Ilaria Mirabile; Parmjit S Jat; Sebastian Brandner; John Collinge
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04-23       Impact factor: 8.090

10.  Carnosine's effect on amyloid fibril formation and induced cytotoxicity of lysozyme.

Authors:  Josephine W Wu; Kuan-Nan Liu; Su-Chun How; Wei-An Chen; Chia-Min Lai; Hwai-Shen Liu; Chaur-Jong Hu; Steven S-S Wang
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.